SwissMedic-2021-0069-V469
Minor variation for application SwissMedic-2021-0069. Minor variation: Container Closure Change for Brextanib — critical change
Variation Number
SwissMedic-2021-0069-V469
Type
Minor
Application
Change
Status
In Progress
Fee
€2,121
Submitted
2023-01-16
Approved
—
Description
Minor variation: Container Closure Change for Brextanib — critical change